NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated July 13, 2026

Huperzine A

Other ·Exploratory record · not publication-reviewed ·Updated July 13, 2026

Huperzine A is a reversible acetylcholinesterase inhibitor isolated from Huperzia serrata and used for memory and acetylcholine support. Human evidence is mostly in Alzheimer disease or other cognitive-impairment populations, not healthy enhancement. It should be treated as a pharmacologically active cholinergic compound with real bradycardia, GI, sleep, and airway cautions.

Publication status

Exploratory record, not a reviewed medical publication.

See the editorial and medical-review policies for the publication gate.

This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.

In short

What the research says.

A quick, data-only summary. The full evidence, dosing, and sources are below.

Huperzine A is an other most often used for may support memory in diagnosed cognitive impairment, may increase cholinergic alertness, studied for alzheimer disease symptom scores. NutriStack rates the overall evidence as emerging. A typical adult dose is 50-200 mcg once or twice daily; avoid escalating without clinician oversight, commonly taken as standardized huperzine a extract with microgram dosing clearly stated. This profile indexes 3 sources.

What it's good for
  • May support memory in diagnosed cognitive impairment1
  • May increase cholinergic alertness2
  • Studied for Alzheimer disease symptom scores1,2
  • May support short-term learning tasks2
What to watch for
  • Nausea, diarrhea, abdominal cramping, or increased salivation
  • Sweating, dizziness, headache, or vivid dreams
  • Slow heart rate or palpitations in susceptible people
  • Pregnancy and breastfeeding due to insufficient safety data2
  • Bradycardia, heart block, sick sinus syndrome, or unexplained syncope

The bottom line

Evidence rating emerging. Most-documented uses: may support memory in diagnosed cognitive impairment, may increase cholinergic alertness, studied for alzheimer disease symptom scores. 3 sources indexed (2009–2013), with 0 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Huperzine A inhibits acetylcholinesterase, slowing acetylcholine breakdown at central and peripheral synapses. It crosses the blood-brain barrier and may also modulate NMDA receptor signaling and oxidative stress in preclinical models. The same cholinergic action can cause nausea, sweating, vivid dreams, bronchospasm, slow pulse, and additive toxicity with cholinesterase-inhibiting drugs.2,1

Class
Acetylcholinesterase-inhibiting alkaloid
Found in food
Huperzia serrata club moss extract, Not present in ordinary foods
Low-status signs
None - huperzine A is not an essential nutrient and has no deficiency state
Absorption
Water-soluble; take with food
Dosing

Dosing & protocol.

Common range
50-200 mcg once or twice daily; avoid escalating without clinician oversight
Recommended form
Standardized huperzine A extract with microgram dosing clearly stated

Food can reduce nausea. Because doses are measured in micrograms, avoid proprietary nootropic blends that duplicate cholinergic ingredients.3

Cost

What it actually costs.

Real-world pricing across three quality tiers. Assumes Standardized Huperzine A capsule.

BudgetBest value
$2 /mo
$0.05 per dose
Mid
$4 /mo
$0.12 per dose
Premium
$9 /mo
$0.30 per dose

Costs assume 100 mcg/day. Premium pricing usually reflects third-party testing and precise microgram dosing. Updated 2026-06-04.

Safety

Full safety detail.

Side effects

  • Nausea, diarrhea, abdominal cramping, or increased salivation
  • Sweating, dizziness, headache, or vivid dreams
  • Slow heart rate or palpitations in susceptible people
  • Insomnia or agitation if taken late
  • Bronchospasm risk in asthma or COPD

Contraindications

  • Pregnancy and breastfeeding due to insufficient safety data2
  • Bradycardia, heart block, sick sinus syndrome, or unexplained syncope
  • Active peptic ulcer disease or severe reflux worsened by cholinergic stimulation1,2
  • Asthma or COPD unless supervised by a clinician
  • Seizure disorder or concurrent cholinesterase inhibitor therapy without medical supervision
Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

2
  • 1Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trialsYang G et al. · PLoS One · 2013

    Possible cognitive and daily-function benefits were reported, but methodological limitations were important.

  • 2Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysisWang R et al. · Journal of Neural Transmission · 2009

    Earlier RCT synthesis reported symptomatic improvement but limited data quality and short follow-up.

Randomized controlled trials

1
  • 3A phase II trial of huperzine A in mild to moderate Alzheimer diseaseRafii MS et al. · Neurology · 2011

    The 400 mcg twice daily arm showed some secondary signals while primary outcomes were limited.

FAQ

Common questions.

Quick answers about Huperzine A, drawn from the data on this page.

What is Huperzine A?

Huperzine A is a reversible acetylcholinesterase inhibitor isolated from Huperzia serrata and used for memory and acetylcholine support. Human evidence is mostly in Alzheimer disease or other cognitive-impairment populations, not healthy enhancement. It should be treated as a pharmacologically active cholinergic compound with real bradycardia, GI, sleep, and airway cautions.

What is Huperzine A used for?

Commonly cited benefits of Huperzine A include: May support memory in diagnosed cognitive impairment; May increase cholinergic alertness; Studied for Alzheimer disease symptom scores; May support short-term learning tasks. NutriStack rates the overall evidence as emerging.

What is a typical dose of Huperzine A?

A typical adult dose of Huperzine A is 50-200 mcg once or twice daily; avoid escalating without clinician oversight. The commonly recommended form is Standardized huperzine A extract with microgram dosing clearly stated. These are general ranges, not personalized advice; confirm the right dose with a clinician.

What are the side effects of Huperzine A?

Reported side effects include nausea, diarrhea, abdominal cramping, or increased salivation, sweating, dizziness, headache, or vivid dreams, slow heart rate or palpitations in susceptible people, insomnia or agitation if taken late, bronchospasm risk in asthma or copd. This is educational information; check with a healthcare professional before use.

How strong is the evidence for Huperzine A?

NutriStack rates this as Emerging, meaning early RCT signal, mechanistic data, or limited human evidence. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.

Use this with your stack

Huperzine A in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.